Clinical Trial Update: Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pamrevlumab vs placebo with systemic corticosteroids in non-ambulatory Duchenne Muscular Dystrophy was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Pamrevlumab (pamrevlumab)

Snippet

Sponsor: Kyntra Bio | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: TERMINATED | Results posted: 2024-03-12